trending Market Intelligence /marketintelligence/en/news-insights/trending/swddoccztfadr0r7gfjo0a2 content esgSubNav
In This List

Xenon Pharmaceuticals raises $29.2M under equity offering program

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Xenon Pharmaceuticals raises $29.2M under equity offering program

Xenon Pharmaceuticals Inc. said it raised about $29.2 million as of July 3 under an equity offering program.

The proceeds are from the sale of 3,440,000 common shares, the Burnaby, British Columbia-based biopharmaceutical company said.

In May, Xenon entered a sales agreement with Stifel Nicolaus & Co. Inc. for the sale of up to $30 million of common shares.